USD 8.6 billion
Report ID:
SQMIG35A2806 |
Region:
Global |
Published Date: March, 2025
Pages:
219
|Tables:
117
|Figures:
72
Global Cardiac Valve Market size was valued at USD 8.6 billion in 2023 and is poised to grow from USD 9.58 billion in 2024 to USD 22.72 billion by 2032, growing at a CAGR of 11.4% during the forecast period (2025-2032).
Technological advancements are proving to be transformative in the management of heart failure and other cardiovascular diseases, reshaping the trajectory of treatment. As the prevalence of cardiac conditions continues to rise, there's a pronounced emphasis on pioneering sophisticated products. This escalating focus on innovation is poised to profoundly influence cardiovascular disease management in the predictable future. Moreover, the introduction of novel products by major industry players is poised to catalyze further growth in the market, propelling advancements and enhancing treatment methodologies.
Anticipated growth in the cardiac valve market between 2023 and 2030 is poised to be fueled by several significant drivers. Among these, the exponential increase in the global population affected by cardiovascular diseases emerges as a notable force propelling this expansion. The surging prevalence of diverse heart-related ailments, spanning from valvular disorders to coronary artery disease, has substantially elevated the demand for cardiac valve replacements. These implants serve as pivotal interventions, instrumental in reinstating optimal cardiac function and notably improving patient outcomes.
Market snapshot - 2025-2032
Global Market Size
USD 8.6 billion
Largest Segment
Cardiac Wall Replacement
Fastest Growth
Growth Rate
11.4% CAGR
To get more reports on the above market click here to Buy The Report
Global Cardiac Valve Market is segmented by Type, Position, Treatment, End User and region. Based on Type, the market is segmented into Trans-Catheter Heart Valve, Tissue Heart Valve, Mechanical Heart Valve and Others. Based on Position, the market is segmented into Mitral Valve, Aortic Valve and Other Position. Based on Treatment, the market is segmented into Cardiac Valve Repair and Cardiac Valve Replacement. Based on End User, the market is segmented into Cardiac Research Institute, Hospital and Clinics, Speciality centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
The cardiac wall repair segment emerges as the foremost contributor to the market share, poised for substantial growth in the forecast period. This segment holds a pivotal role in catering to the requirements associated with rectifying or reconstructing the heart's compromised or irregular walls.
The cardiac wall replacement segment holds a crucial position within the cardiac valve market, focusing specifically on addressing issues related to damaged or structurally compromised heart walls. This segment encompasses a range of techniques, procedures, and devices tailored to repair, reconstruct, or reinforce the walls of the heart. It plays a vital role in addressing conditions such as aneurysms, myocardial infarction-related damage, congenital defects, and other structural abnormalities affecting the heart walls.
The tissue/bioprosthetic valves segment stands as the dominant market shareholder and is poised for substantial growth in the forthcoming forecast period. This segment denotes a specialized category of valves utilized in the replacement of impaired or ailing heart valves. Crafted from animal tissue, typically sourced from cows or pigs, these valves undergo meticulous chemical treatment and processing to render them suitable for implantation.
Transcatheter or percutaneous heart valves play a pivotal role in revolutionizing cardiac care within the cardiac valve market. These valves represent a minimally invasive alternative to traditional open-heart surgeries for valve replacement. Using catheter-based techniques, these specialized valves can be delivered and implanted within the heart, often through arteries or veins, without the need for open-chest procedures.
To get detailed analysis on other segments, Request For Free Sample Report
In 2022, the North America Market asserted its dominance by securing a commanding market share of 45.50%. This notable achievement owes itself to a convergence of influential factors shaping the region's leadership position. The dominance is fueled by advanced medical expertise and the introduction of revolutionary cardiac valve solutions, both playing pivotal roles in this landscape. Furthermore, the implementation of stringent regulatory frameworks overseeing the production and upkeep of heart valve devices significantly contributes to the region's success.
The Asia-Pacific emerges as a promising frontier for market growth, propelled by several influential factors driving its expansion. A significant population base, increasing healthcare expenditures, and ongoing improvements in healthcare infrastructure contribute to the rapid development of this landscape. Particularly, nations like China, India, and Japan take the lead in advancing the market in the region, playing pivotal roles in its substantial expansion.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Rise in Burden Exerted by Valvular Heart Diseases
Stringent Government Regulations
Request Free Customization of this report to help us to meet your business objectives.
The Global Cardiac Valve Market boasts a dynamic competitive landscape, featuring a blend of well-established brands, emerging players, and niche producers. Innovation stands as a pivotal competitive factor. Foremost brands heavily invest in research and development, introducing new flavors, packaging formats, and health-centric variations to meet evolving consumer preferences. Frequently, these brands set the trends within the industry, driving its direction and development.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. The rising prevalence of valvular heart disease, particularly aortic stenosis impacting the aortic valve, has fueled the growth of the market for Cardiac Valve devices and equipment. Aortic stenosis, a form of valvular heart ailment, causes stiffening of the aortic valve, impeding the regular flow of blood. To address this condition, the minimally invasive transcatheter aortic valve replacement (TAVR) procedure is employed.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 8.6 billion |
Market size value in 2032 | USD 22.72 billion |
Growth Rate | 11.4% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Cardiac Valve Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Cardiac Valve Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Cardiac Valve Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Cardiac Valve Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
Cardiac Valve Market size was valued at USD 7.67 Billion in 2023 and is poised to grow from USD 8.17 Billion in 2024 to USD 13.51 Billion by 2032, growing at a CAGR of 6.50% during the forecast period (2025-2032).
The Global Cardiac Valve Market boasts a dynamic competitive landscape, featuring a blend of well-established brands, emerging players, and niche producers. Innovation stands as a pivotal competitive factor. Foremost brands heavily invest in research and development, introducing new flavors, packaging formats, and health-centric variations to meet evolving consumer preferences. Frequently, these brands set the trends within the industry, driving its direction and development. 'Medtronic', 'Edwards Lifesciences Corporation', 'Boston Scientific Corporation', 'LivaNova PLC', 'Abbott', 'CryoLife Inc', 'On-X Life Technologies Inc.', 'Colibri Heart Valve', 'JenaValve Technology Inc.', 'TTK HealthCare', 'LivaNova PLC', 'Abbott Laboratories', 'Colibri Heart Valve LLC', 'Artivion Inc.', 'Lepu Medical Technology Co Ltd.'
The expanding geriatric demographic, coupled with a shift towards sedentary lifestyles, stands as a significant driver behind the growing market. Advancements in heart valve technology and a heightened awareness of surgical interventions are further propelling this growth, especially with the increasing preference for minimally invasive procedures. For instance, the American College of Cardiology notes that approximately 5 million Americans are affected by heart valve disease annually.
The burgeoning market for Cardiac Valve devices is propelled by multiple factors, prominently including the escalating incidence of heart valve illnesses alongside the introduction of novel and enhanced cardiac valves securing regulatory endorsements. This growth trajectory is distinctly fueled by the increasing prevalence of heart valve diseases, a pivotal driving force within this sector. Notably, conditions like rheumatic heart disease, impacting 39 million individuals globally as per the World Heart Federation's 2022 data, significantly contribute to this trend. Rheumatic heart disease ensues when rheumatic fever chronically affects the heart valves, underscoring the imperative need for innovative cardiac valve solutions.
In 2022, the North America Market asserted its dominance by securing a commanding market share of 45.50%. This notable achievement owes itself to a convergence of influential factors shaping the region's leadership position. The dominance is fueled by advanced medical expertise and the introduction of revolutionary cardiac valve solutions, both playing pivotal roles in this landscape. Furthermore, the implementation of stringent regulatory frameworks overseeing the production and upkeep of heart valve devices significantly contributes to the region's success.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35A2806
[email protected]
USA +1 351-333-4748